Cite
MLA Citation
Stéphane Ducassou et al.. “Benefits of rituximab as a second‐line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.” British journal of haematology, vol. 177, 2017, pp. 751–758. http://access.bl.uk/ark:/81055/vdc_100046455809.0x00005c